Nuwellis (NUWE) Competitors $0.89 -0.04 (-4.09%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUWE vs. QTI, XAIR, LFWD, VVOS, PETV, NRXS, PAVM, ALUR, CODX, and ICUShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include QT Imaging (QTI), Beyond Air (XAIR), ReWalk Robotics (LFWD), Vivos Therapeutics (VVOS), PetVivo (PETV), NeurAxis (NRXS), PAVmed (PAVM), Allurion Technologies (ALUR), Co-Diagnostics (CODX), and SeaStar Medical (ICU). These companies are all part of the "medical equipment" industry. Nuwellis vs. QT Imaging Beyond Air ReWalk Robotics Vivos Therapeutics PetVivo NeurAxis PAVmed Allurion Technologies Co-Diagnostics SeaStar Medical Nuwellis (NASDAQ:NUWE) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, community ranking, analyst recommendations, valuation, profitability, earnings, dividends and risk. Does the MarketBeat Community prefer NUWE or QTI? Nuwellis received 22 more outperform votes than QT Imaging when rated by MarketBeat users. CompanyUnderperformOutperformNuwellisOutperform Votes2253.66% Underperform Votes1946.34% QT ImagingN/AN/A Is NUWE or QTI more profitable? QT Imaging has a net margin of 0.00% compared to Nuwellis' net margin of -169.54%. QT Imaging's return on equity of 0.00% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets Nuwellis-169.54% -28,159.25% -207.24% QT Imaging N/A N/A -65.94% Which has more risk & volatility, NUWE or QTI? Nuwellis has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, indicating that its share price is 120% less volatile than the S&P 500. Does the media refer more to NUWE or QTI? In the previous week, QT Imaging had 3 more articles in the media than Nuwellis. MarketBeat recorded 3 mentions for QT Imaging and 0 mentions for Nuwellis. Nuwellis' average media sentiment score of 1.87 beat QT Imaging's score of 0.29 indicating that Nuwellis is being referred to more favorably in the media. Company Overall Sentiment Nuwellis Very Positive QT Imaging Neutral Do institutionals & insiders hold more shares of NUWE or QTI? 3.1% of Nuwellis shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 2.6% of Nuwellis shares are owned by company insiders. Comparatively, 75.4% of QT Imaging shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has better valuation & earnings, NUWE or QTI? QT Imaging has lower revenue, but higher earnings than Nuwellis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuwellis$8.74M0.45-$20.21M-$38.53-0.02QT Imaging$4.00M4.28-$4.03MN/AN/A Do analysts rate NUWE or QTI? Nuwellis currently has a consensus price target of $17.00, suggesting a potential upside of 1,805.83%. Given Nuwellis' stronger consensus rating and higher possible upside, equities research analysts clearly believe Nuwellis is more favorable than QT Imaging.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nuwellis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50QT Imaging 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryNuwellis and QT Imaging tied by winning 8 of the 16 factors compared between the two stocks. Remove Ads Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUWE vs. The Competition Export to ExcelMetricNuwellisElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.90M$3.09B$5.28B$7.36BDividend YieldN/A1.80%5.11%4.32%P/E Ratio-0.0114.6721.6317.68Price / Sales0.4543.53371.0892.88Price / CashN/A44.0938.1534.64Price / Book0.053.286.373.94Net Income-$20.21M$94.03M$3.20B$247.45M7 Day Performance3.72%-4.07%1.79%0.48%1 Month Performance-23.10%-9.96%-9.41%-7.08%1 Year Performance-92.39%-22.49%9.61%-0.35% Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUWENuwellis3.2656 of 5 stars$0.89-4.1%$17.00+1,805.8%-92.8%$3.90M$8.74M-0.0170QTIQT ImagingN/A$0.60-0.1%N/A-43.5%$16.28M$4.00M0.00N/AGap UpXAIRBeyond Air4.2175 of 5 stars$0.23-0.9%$3.67+1,467.0%-82.3%$16.10M$3.02M-0.2270News CoverageGap UpLFWDReWalk Robotics2.6409 of 5 stars$1.44+0.7%$9.00+525.0%-71.6%$15.31M$25.66M-0.5860Short Interest ↓News CoverageGap DownVVOSVivos Therapeutics1.7514 of 5 stars$2.25-3.4%$6.10+171.1%-20.9%$13.25M$15.03M-0.40160Analyst ForecastNews CoverageGap DownPETVPetVivoN/A$0.55+9.9%N/A-16.6%$13.07M$1.05M-1.2220News CoverageGap DownHigh Trading VolumeNRXSNeurAxisN/A$1.73-3.4%N/A-44.3%$12.48M$2.69M-0.9419High Trading VolumePAVMPAVmed3.961 of 5 stars$0.72+6.2%$19.00+2,538.2%-62.5%$12.31M$3.00M-0.1790Short Interest ↑ALURAllurion Technologies2.257 of 5 stars$2.54+4.5%$22.83+799.0%-96.0%$12.18M$32.11M-0.21501Short Interest ↑Negative NewsGap DownCODXCo-Diagnostics4.0688 of 5 stars$0.36-1.8%$1.00+175.9%-70.3%$12.17M$3.92M-0.26100Short Interest ↓Gap DownICUSeaStar Medical0.1255 of 5 stars$1.29-1.5%N/A-92.2%$11.25M$135,000.00-0.112Short Interest ↑Gap Up Remove Ads Related Companies and Tools Related Companies QTI Alternatives XAIR Alternatives LFWD Alternatives VVOS Alternatives PETV Alternatives NRXS Alternatives PAVM Alternatives ALUR Alternatives CODX Alternatives ICU Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NUWE) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredCould this be my downfall?I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?Recently, President Trump decided to kill the coin, for good reason. It now costs 4 cents to make a single pen...Paradigm Press | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
